#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Peritoneal neoplasm Malignant melanoma Loss of consciousness Cutaneous T-cell lymphoma refractory Chronic graft versus host disease in intestine Progressive multifocal leukoencephalopathy Angiosarcoma recurrent Sjogren's syndrome Nephroblastoma Skin angiosarcoma Ataxia telangiectasia Retinitis pigmentosa Autoinflammation with infantile enterocolitis Erythema More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Andersen-Tawil syndrome – Trials in Disease Alexander disease – Diagnostics Mantle cell lymphoma stage III – Life with Disease Richter’s syndrome – Treatment Loeys-Dietz syndrome – Trials in Disease Mantle cell lymphoma refractory – Basic Information Waldenstrom’s macroglobulinaemia Andersen-Tawil syndrome – Basic Information Leiomyosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ATIRMOCICLIB ABIRATERONE DECANOATE Magnesium Stearate Febuxostat Hemihydrate Metformin Embonate Utreloxastat GLYCYL-TYROSINE Forimtamig Ceftriaxone Sodium Posdinemab TRIMIPRAMINE MALEATE BLEXIMENIB Fezolinetant Repotrectinib Arachis Hypogaea (762) Darunavir GRAPHITE ANGIOTENSIN II Esomeprazole Inclisiran More therapies…

    Learn about Your Condition

    Choroidal dystrophy Chronic granulomatous disease Portal hypertension Pemphigus Frostbite Small fibre neuropathy Ventricular tachycardia Abdominal wall pain Ureteric cancer Relapsing multiple sclerosis Brain cancer metastatic Immune-mediated enterocolitis Rosai-Dorfman syndrome Brain neoplasm malignant Lung neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Bacs-Kiskun Varmegyei Oktatokorhaz

Bacs-Kiskun Varmegyei Oktatokorhaz

Nyiri Ut 38, Kecskemet, 6000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Hungary Italy +5

  • Study of dapagliflozin effects in patients hospitalized with acute heart failure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    Czechia Hungary Poland

  • Study Comparing Paclitaxel, Carboplatin, and Oregovomab with Paclitaxel, Carboplatin, and Placebo for Patients with Advanced Ovarian Cancer

    Not recruiting

    3 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Oregovomab
    Belgium Czechia Hungary Italy Spain

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Infliximab
    Austria Belgium Czechia France Germany Hungary +5

  • Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    • Gastric cancer
    Investigated Drugs:
    • Docetaxel
    • Durvalumab
    • Fluorouracil
    Belgium Denmark France Germany Hungary The Netherlands +2

  • Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Postoperative wound infection
    Investigated Drugs:
    • Doxycycline Hyclate
    Germany Hungary Ireland Italy Poland Portugal +1

  • Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Capivasertib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +1

  • Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Db-1303
    • Capecitabine
    • Paclitaxel
    Belgium France Germany Hungary Italy Poland +1

  • Study of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin
    • Olaparib
    • Capecitabine
    Austria Belgium Bulgaria France Germany Hungary +3

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7
Previous Page
1 … 6 7 8 9 10 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!